Our vision
Building towards end-to-end peptide solutions.
One partner from first binder to commercial supply. Discovery and GMP manufacturing are in place today, and a dedicated peptide plant is coming up at Unit 7.
Peptide plant coming up here
Roadmap
How our CDMO is growing.
What partners can use today, what we are building now, and where we are heading.
-
In place today
Discovery to GMP API
- AI design with phage display
- Parallel synthesis and libraries
- Hit-to-lead and lead optimisation
- Process development and analytics
- Multi-kg GMP peptide API at Unit 7
-
Building now
Dedicated peptide plant
- Purpose-built peptide plant at Unit 7, Visakhapatnam
- Larger GMP capacity for clinical supply
- Inside a USFDA, EU-GMP and WHO-GMP approved site
-
Next
Commercial-scale supply
- Long-term development-and-supply partnerships
- Commercial manufacturing for approved peptide therapeutics
- One team across the full product lifecycle
Our strategy
Grow capacity, keep the science close.
As we scale, the chemists who find and optimise your peptide stay with it through development and manufacture.
Science first
Every step grounded in data, reproducibility and quality.
Capacity ahead of demand
GMP capacity grows before your program needs it, not after.
One team, whole lifecycle
No hand-offs between discovery, development and supply.
Grow with us.
To discuss our roadmap or arrange a meeting, get in touch with our team.